AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.

Sample informed consent form for Botox administration.

Article under preparation This article is currently available only in Russian. You can switch the language in the top language bar to view the Russian version, or check back soon — the English translation will be available shortly.  

When designing comprehensive programs, it is reasonable to consider procedures using hardware-based methods followed by correction through minimally invasive approaches (injection techniques, chemical peels).

When does a product used in cosmetology provide a 100% effect, and when only a partial one? What can help разобраться this?

On the correction of a gummy smile, mimic wrinkles, and age-related changes in the lower third of the face and neck, as well as combined techniques for the use of botulinum toxin type A.

On the correction of mimic wrinkles and age-related changes in the upper third of the face (forehead, glabella, eyebrows, eyes, nose) using botulinum toxin type A.

Allergan Announces Results of Higher Dose BOTOX® Cosmetic (onabotulinumtoxin A) for the Treatment of Moderate to Severe Glabellar Lines.

Techniques for performing botulinum neurotoxin injections in the perioral area. Injection points, dosages, injection techniques, and safety considerations. Combining botulinum toxin therapy with other aesthetic correction methods for the lower third of the face.

Botulinum toxin therapy is one of the most commonly used procedures when working with the perioral area. However, in this region, injections of botulinum neurotoxin can lead to various complications associated with muscle imbalance.